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ABSTRACT 
 
Scope:  Iron is an essential nutrient.  However, in animal models, excess unabsorbed dietary 
iron residing within the colonic lumen has been shown to exacerbate inflammatory bowel 
disease and intestinal cancer.  Therefore the aims of this study were to screen a panel of 
alginates to identify a therapeutic that can chelate this pool of iron and thus be beneficial for 
intestinal health. 
 
Methods and results: Using several in vitro intestinal models it is evident that only one 
alginate (Manucol LD) of the panel tested was able to inhibit intracellular iron accumulation as 
assessed by iron mediated ferritin induction, transferrin receptor expression, intracellular 59Fe 
concentrations and by measuring iron flux across a Caco-2 monolayer. Additionally, Manucol 
LD suppressed iron absorption in mice which was associated with increased faecal iron levels 
indicating iron chelation within the gastrointestinal tract. Furthermore, the bioactivity of 
Manucol LD was found to be highly dependent on both its molecular weight and its unique 
compositional sequence. 
 
Conclusion: Manucol LD could be useful for the chelation of this detrimental pool of 
unabsorbed iron and it could be fortified in foods to enhance intestinal health. 
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INTRODUCTION 
Iron is an essential nutrient with many cellular functions reliant upon iron-catalysed processes 
such as DNA synthesis and ATP generation.[1, 2] Total body iron levels in adult males is 
between 3000 – 4000 mg, with a daily nutritional need for iron of 20 mg which is mostly 
required for erythropoiesis.[3]  This daily requirement of iron is ingested from the diet; however 
it is known that only 0.7 – 22.9 % of ingested non-heme iron is absorbed within the small 
bowel.[4]  As a consequence the remaining dietary iron resides within the large bowel for hours 
to days.  Recent reports have concluded that this ‘luminal iron’ (iron present within the lumen 
of the colon) has a detrimental effect on intestinal health.[5, 6]  Most notably two recent murine 
studies have shown that removal of dietary iron from models of inflammatory bowel disease 
(IBD) and intestinal cancer resulted in a suppression of disease phenotype, whilst 
consumption of excess dietary iron exacerbated the conditions.[5, 6]  How this excess iron is 
mediating these effects is unknown, however it could be via oncogenic signalling (the Wnt 
signalling pathway),[7] the generation of reactive oxygen species (ROS),[8-10] or through the 
modulation of the intestinal microbiome. [6, 11] 
 
Iron chelation represents a platform for therapeutic intervention, whereby ligated iron would 
be neutralised and unable to partake in any toxicity-related processes; this has indeed been 
demonstrated in the context of chelation of excess systemic iron, where the use of iron 
chelators have been shown to have beneficial effects.[12]  However, with respect to luminal 
iron a therapeutic agent must not demonstrate systemic iron binding and iron chelation must 
solely take place within the gastrointestinal tract.  As such, a compound that demonstrates 
iron binding potential whilst having a limited bioavailability needs to be identified.   Sodium 
alginates are a fibre found throughout many foods which demonstrate these physico-chemical 
properties.[13, 14]   
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Alginates sourced from algae are formed of unbranched, 1-4 linked β-D-mannuronic acid (M) 
and α-L-guluronic acid (G).  The arrangement of G and M residues along the polymeric back-
bone sequence is ordered being heteropolymeric (e.g. GMGMGM) or homopolymeric (e.g. 
MMMGGG).[15]  The physical properties of alginate can differ depending on their molecular 
weight and GM sequence; these structural differences give rise to a plethora of possible 
structural compositions.  How these compositional differences may alter the biochemical 
actions of alginates is unknown, and in particular how they influence iron binding in vitro and 
in vivo is not known.  As such, the impact of a range of alginates (representing different 
chemical compositions) on in vitro and in vivo cellular iron metabolism was assessed.  Further 
to this, the physico-chemical properties of alginate which are crucial for its effects on cellular 
iron metabolism were examined to reveal the alginate chemical composition required for 
luminal iron chelation.  Results from these experiments identify an alginate which is 
nutritionally beneficial and likely to be useful in enhancing intestinal health. 
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MATERIALS AND METHODS 
Cell culture 
RKO cells were grown in growth medium which consisted of Dulbecco’s Modified Eagles 
Medium (DMEM) supplemented with foetal calf serum (FCS) (10 % v/v), penicillin (100 U ml -
1) and streptomycin (0.1 mg mL-1).  Caco-2 cells were grown using a similar growth medium 
which was supplemented with non-essential amino acids (1 % v/v).  Both cell lines were 
purchased from the American Type Culture Collection (ATCC). 
 
In experiments with iron co-incubation, a standard protocol was employed as previously 
described.[13]  Throughout all experiments the form of iron used was FeSO4.  To create 
alginate stimulation media, alginate (2 % w/v in DI H2O) was mixed with growth medium with 
or without iron (FeSO4∙7H2O, 100 μM) to create a resultant 0.3 % alginate medium, with or 
without iron supplementation.  These stimulation media were cultured with cells for 24 hours.  
After this time period, media was removed, cells washed with PBS and lysed in RIPA lysis 
buffer (1% 4-Nonylphenyl poly(ethylene glycol), 0.5% sodium deoxycholate, 0.1% sodium 
dodecyl sulphate (w/v) in DI H2O).  
 
Caco-2 monolayer  
Caco-2 cells were seeded into pre-treated collagen-coated 6-well transwell inserts at a 
concentration of 4 x 105 cells mL-1.  Cells were grown for 20 days post confluency.  Prior to 
culture with iron and/or alginate, cell medium was changed to FCS-free Minimum Essential 
Medium (MEM) as previously reported.[16]  Subsequently, cells were co-cultured with iron 
(FeSO4∙7H2O, 100 μM) and/ or alginate (0.3 %) as described above.  To create 59Fe iron 
media, a stock solution of iron (FeSO4∙7H2O (108.9 mg, 10 mM) and sodium ascorbate (396 
mg, 500 mM)) into DI H2O (40 mL) was spiked with 59FeCl3 to reach a radiation concentration 
of 10,000 counts per minute (CPM) per well.  This stock was diluted into the media to create 
the 100 μM FeSO4∙7H2O as detailed above.  To the apical chamber, FCS-free MEM with 59Fe 
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spiked iron with or without alginate (2 mL) was added.  At 0.5, 4 and 24 hour time points, 
samples were removed from the apical chamber.  After 24 hours, media was removed, the 
cells washed with Versene (0.2 g L-1 EDTA in PBS) and lysed in RIPA buffer. Samples 
collected were assessed for iron concentration using scintillation counting. 
 
Western blotting 
Cells were incubated in iron (FeSO4∙7H2O, 100 μM) and or alginate (0.3 % w/v in DI H2O) or 
D-glucuronic acid (0.3 % w/v in DI H2O) supplemented growth media for 24 hours prior to lysis 
in RIPA buffer.  Western blotting was performed as previously described, with monoclonal 
antibodies to ferritin (1:5000, Abcam, Rabbit AB69090), β-actin (1:5000, Abcam, Mouse 
AB8226) and TfR1 (1:1000, Invitrogen, H68.4).[13] All blots were subject to densitometry 
analysis using ImageJ analysing software. 
 
In vivo 59Fe experiments 
All in vivo experiments were carried out under Home Office approved conditions and Animal 
care and the regulation of scientific procedures met the criteria laid down by the United 
Kingdom Animals (Scientific Procedures) Act 1986.  Male, 6 week year old, CD1 mice (Charles 
Rivers, UK) in groups of 4-8 were used in 59Fe absorption experiments.  All mice were starved 
12 hours prior to gavage and post administration mice were given access to water and food 
ad libitum.  
 
A 59Fe spiked iron gavage solution was prepared by dilution of a Fe(II) stock solution 
(FeSO4∙7H2O, 20 mM in 0.1 M HCl) into HEPES, a physiological buffer devoid of divalent 
metal cations (HEPES, 16 mM pH = 7.4, NaCl 125 mM) to a concentration of 250 μM Fe(II).  
Administration of alginate solutions (8 % w/v in DI H2O, 100 μL) to half of the mice was 
performed immediately after gavage of the prepared radio-labelled iron (100 μL), whereas the 
other half received an iron only gavage and no alginate.  All mice were housed in metabolic 
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chambers for 48 hours prior to culling to allow the collection of faecal samples.  After 48 hours, 
mice were culled and dissected.  Intestinal sections (duodenum, jejunum, ileum and colon) 
were flushed once with a sodium chloride solution (ca. 15 mL, 0.15 M) and detection of iron 
concentrations was performed within these intestinal sections as previously reported.[17]  
Carcass CPM measurements were performed on a whole body animal counter (LIVE-1, 
Technical Associates, Canoga Park, CA). 
 
Heat degradation and viscosity measurements 
Aqueous Manucol DH aliquots (10 mL) were heated at 100 °C for set time points.  All viscosity 
measurements were performed at 25 °C and alginate concentrations that were used were 
within the kinematic range of the viscometer (usually from 0.1 – 1 mg mL-1).  Viscosities were 
measured on a Cannon-Ubbelohde glass viscometer (Cannon instruments), size 50, with a 
kinematic viscosity range of 0.8 – 4 mm2 s-1.  
 
Analytical ultracentrifugation 
Sedimentation velocity and sedimentation equilibrium experiments were performed on a 
Beckman Optima XL-I analytical ultracentrifuge (AUC) equipped with Rayleigh Interference 
Optics and a 30 mW laser wavelength λ = 675 nm as previously reported.[18]  
 
AlgE1 Plasmid extraction and enzyme production 
Agar blocks inoculated with JM 109 containing plasmid pHH1 encoding alginate epimerase 
enzyme 1 (AlgE1) was kindly donated from Helga Ertesvåg (Norwegian University of Sciences 
and Technology).  AlgE1 production was performed according to the previously published 
protocol.[19]   
 
Assessing for activity of AlgE1 and preparation of Epimerised LD 
To screen the purified enzyme fractions for epimerisation activity, aqueous Manucol LD (0.1%, 
(w/v)) in DI H2O was prepared.  Manucol LD solution (2 mL) was mixed with the enzyme 
9 
 
fractions (1 mL) and MOPS buffer (80 mM, 1 mL) supplemented with CaCl2∙2H2O (4 mM).  
The resultant mixture was incubated at 37 °C for 2 hours.  To quench the epimerisation, EDTA 
(50 mM) was added and the subsequent mixtures were extensively dialysed against DI H2O 
at 4 °C.  The resultant solutions were used directly in the circular dichroism (CD) spectrometer.  
CD measurements were recorded on a Jasco J-810 CD spectropolarimeter using a 1 cm path 
length, blackened, quartz cell.  The selected active fraction was used to prepare Epimerised 
Manucol LD (EpLD) for cell culture experiments.  Aqueous Manucol LD (0.2 %, w/v) was mixed 
with MOPS buffer (180 mM) supplemented with CaCl2∙2H2O (40 mM) and the active enzyme 
(20 mL).  The resultant solution was agitated at 37 °C for 24 hours, before enzyme deactivation 
was initiated with the addition of EDTA (0.5 M).  The mixture was then extensively dialysed at 
4 °C.  The subsequent alginate product was pH adjusted (pH = 7.4) and concentrated in vacuo. 
 
High resolution NMR 
1H NMR spectra were acquired on a Bruker Avance III 600 MHz instrument equipped with a 5 
mm TCI Cryoprobe. The residual solvent resonance was further suppressed using a NOESY 
presto pulse sequence. A total of 32 transients and 16 steady state scans were acquired with 
16384 complex data points. The spectral width was set to 7184 Hz and the sample 
temperature to 340 K.  The free induction decays were multiplied with a 0.3 Hz broadening 
exponential window function and zero filled to 32768 real data points prior to Fourier 
transformation. The spectra were then manually phase and baseline corrected, using a spline 
baseline correction. Signals for the anomeric protons of the different alginate constituents were 
fitted to lorentzian lines. All data processing and analysis was performed using the matlab 
based MetaboLab software package.[20]   
 
Statistical analysis 
All experiments were performed at least in triplicate unless otherwise stated.  Data was 
processed using Microsoft excel and results are presented as means with standard errors of 
the mean (+/- SEM).  The single-factor analysis of variance (ANOVA, Analysis ToolPak, 
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Microsoft Corporation) was used to determine significant differences between the means of 
three or more independent (unrelated) groups.  The unpaired t-test was used to statistically 
compare mean values between two unrelated data sets within a group.  A level of significance 
was set to p < 0.05 for both tests of significance. 
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RESULTS 
 Manucol LD demonstrates iron chelation in vitro 
To screen the iron binding potential of the range of alginates used in this study, RKO cells 
were challenged with iron (100 μM) in the presence or absence of sodium alginates (Manucol 
LD (LD), Manucol DH (DH), Manugel GHB (GHB), LFR5/60 (LFR), KELTONE (KEL), 
PROTANAL RF6650 (RF) and PROTSEA AFH (AFH), 0.3 % w/v) for 24 hours and cells were 
then subsequently assayed for ferritin expression; a surrogate marker for cellular iron levels 
(Figure 1A).  As expected treating cells with iron supplemented media alone induced ferritin 
expression (p < 0.05).   Only one alginate (Manucol LD) was able to significantly decrease the 
iron induced ferritin response by 60 % (p < 0.05).  Similarly, culture of RKO cells at lower 
concentrations of iron (1 and 10 μM) in the presence or absence of alginates (LD, DH, GHB, 
LFR, KEL, RF and AFH, 0.3 % w/v) demonstrated that Manucol LD was the only alginate to 
significantly reduce ferritin expression by 70, 88 and 68 % at 1, 10 and 100 μM concentrations 
of iron respectively compared to the iron only control (p < 0.05) (Figure 1B).  DH, GHB and 
LFR only inhibited ferritin expression at 10 μM iron by 54, 47 and 92 % respectively (p < 0.05) 
(Supporting Information Figure S1).  Manucol LD was the only alginate to demonstrate 
bioactivity at all concentrations of iron.   
 
In order to fully verify the iron chelation ability of Manucol LD in vitro, RKO cells were 
challenged with iron (100 μM) with or without Manucol LD (0.3 % w/v) for 24 hours before 
being assessed for direct intracellular iron concentrations (Figure 1C) and Transferrin 
Receptor 1 (TfR1) expression (Figure 1D).  RKO cells treated with iron resulted in cellular iron 
loading (ca. 50 nM total cellular iron); the basal levels of iron within the control group were not 
measureable by this assay.  It was found that Manucol LD significantly decreased cellular iron 
loading by 62 % (p < 0.05) (Figure 1C).  This was associated with a statistical increase in TfR1 
expression by ca. 50 % (p < 0.05) compared to iron alone, indicating that Manucol LD is 
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binding the supplemented iron present in the media hindering its intracellular uptake (Figure 
1D). 
 
Manucol LD demonstrates iron chelation in an in vitro model of the intestinal 
lumen 
Using radiolabelled iron-spiked cell culture media, Manucol LD significantly decreased 
intracellular iron concentrations by 70 % (p < 0.05) within the Caco-2 monolayer compared to 
the iron only control (Figure 2A).  By assessing the levels of iron within the apical chamber 
during the experiment it could be determined that iron was retained within this compartment 
(Figure 2B).  Co-incubation with Manucol LD at both 4 and 24 hours inhibited cellular iron 
uptake by the Caco-2 cells by 60 % (p < 0.05) compared to the iron only control from the apical 
compartment.  These results validate the observation that Manucol LD is binding iron in the 
media thus preventing its cellular internalisation.   
 
Manucol LD demonstrates iron chelation within the gastrointestinal tract in vivo 
Administration of Manucol LD resulted in significantly decreased carcass iron concentrations 
by 71 % (p < 0.005) compared to an iron only cohort (Figure 3A).  This equates to only 13 % 
of the total iron administered being absorbed when Manucol LD was present compared to 46 
% when it was absent (Supporting Information Figure S2).  In addition, there was a 
concomitant increase in faecal iron concentrations of 45 % (p < 0.05) in mice administered 
Manucol LD compared to mice administered iron alone (Figure 3B).    To fully verify the iron 
chelation potential of Manucol LD throughout the gastrointestinal tract,  the stomach, 
duodenum and colon were assayed for iron concentration and it was found that in all 
gastrointestinal tissues there were statistically decreased iron concentrations when mice were 
administered Manucol LD compared to iron alone (Figure 3C).  Specifically, a significant 
decrease of 53, 60 and 52 % (p < 0.05) in the stomach, duodenum and colon was found 
respectively.  Moreover, the iron concentrations significantly increases from the stomach to 
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the duodenum to the colon (stomach → duodenum 73% increase, stomach → colon 83 % 
increase (p < 0.05)).  All mice received the same concentration of 59Fe radioactive gavage 
(Figure 3D).   
 
 Chemical characterisation of alginates 
To establish why Manucol LD demonstrated bioactivity and the other alginates did not, 
chemical characterisation of the alginate series was performed.  Both assessment of 
molecular weight by analytical ultracentrifugation (AUC) (Supporting Information Figure S3) 
and G:M composition by nuclear magnetic resonance (NMR) (data not shown) was 
performed.[21, 22]  A summary of these results are described in Table 1.  Manucol LD was 
found to have a molecular weight distribution of 145 kDa.  Manucol LD was also found to have 
a G:M ratio of 38:62, however, this composition was not unique to Manucol LD as Manucol 
DH had a similar G:M ratio of 40:60.   
 
Alginate iron chelation is molecular weight dependent 
Since Manucol DH and Manucol LD shared similar G:M composition homology, yet Manucol 
DH was found to have a higher molecular weight than Manucol LD (cf. 170 vs 145 kDa), to 
determine if the difference in bioactivity was due to the molecular weight of Manucol DH, 
Manucol DH was subject to heat degradation to produce smaller molecular weight average 
alginate degrade products (ADPs) as previously described.[23]  The relative viscosity 
decreases as expected with longer heating times, and the mean values for intrinsic viscosity 
obtained can be calibrated against heating time (Figure 4A).  The resultant ADPs (0.3 % w/v) 
were subsequently co-cultured in the presence or absence of iron (100 μM) in vitro for 24 
hours to examine their effects on iron induced ferritin expression (Figure 4B).  Co-culturing 
RKO cells with native Manucol DH does not demonstrate any iron chelation effects as 
described previously (Figure 1A).  Heat degradation of Manucol DH for 20 and 40 mins and 
subsequent co-culture of these ADPs on RKO cells also reveals no iron binding ability.  
However, heat degradation for 80 and 160 min statistically reduced iron-mediated ferritin 
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expression by ca. 50 % (p < 0.05), but not to the extent of Manucol LD (Figure 4B).  Further 
degradation (250 min) resulted in a loss of this bioactivity.  As a further control, the effect of 
the monomeric-acid unit on cellular iron metabolism was assessed.  D-glucuronic acid (DGA) 
(0.3 % w/v) was co-cultured alongside RKO cells in the presence or absence of iron (100 μM).  
There was no statistical reduction in iron induced ferritin expression or 59Fe levels when cells 
were cultured alongside DGA compared to iron only (Figure 4C & D).  
 
Alginate iron chelation is composition dependent 
Manucol LD and Manucol DH have similar G:M chemical compositions but this does not 
preclude differences in GM sequence structure.  To examine this they were both subject to 
high resolution NMR to allow calculation of their respective monad (G/M), diad (GM/GG/MM) 
or triad (GMG/GGM/MGM/MMG) concentrations.[24]  NMR spectra for Manucol LD and 
Manucol DH were acquired and analysed using the correlations described and transformed 
free-induction decays were fitted to lorentzian curves to allow calculation of the specific 
monads, diads and triads (Figures 5A and 5B) according to a standard protocol.[24]  
Calculation of the major differences between Manucol LD and Manucol DH revealed that 
Manucol LD contained 12 % more MM diads than Manucol DH.  Similarly, Manucol DH 
contained 8 % more GM diads than Manucol LD.    
 
To interrogate the dependence on G:M composition and sequence structure, an alginate 
epimerase enzyme (AlgE1) was produced and utilised for the M→G conversion of Manucol 
LD.  Epimerisation of native Manucol LD by AlgE1 resulted in an approximate two-fold 
increase in guluronate residues on epimerised Manucol LD (EpLD) resulting in a new G:M 
ratio of 77:23; the highest G-unit concentration alginate out of the series as assessed by 
circular dichroism spectroscopy (Figure 5C).  There was also very little absorption present at 
λ = 280 nm on the UV-Vis indicating negligible AlgE1 protein contaminant.  To examine the 
effects of epimerisation of Manucol LD on iron induced ferritin expression, RKO cells were co-
cultured in the presence or absence of Manucol LD or EpLD with or without iron for 24 hours 
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before ferritin expression was examined (Figure 5D).  Ferritin expression in RKO cells treated 
with iron was significantly higher than that of control media only, as expected.  Manucol LD 
statistically diminished ferritin expression by 57 % compared to iron only control (cf. 60 % in 
previous studies) (p < 0.005).  EpLD did not reduce ferritin expression compared to the iron 
only control, and expression was statistically increased by 63 % compared to Manucol LD 
treatment (p < 0.005) (Figure 5D). 
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DISCUSSION 
The detrimental effect of excess iron within the colon has previously been reported.[5, 6, 25, 
26]  The ingestion of high amounts of red and processed meats, foods that contain high levels 
of iron, have also been implicated in gastrointestinal disease.[27, 28]  Exactly how iron is 
mediating disease progression within the large bowel is currently unknown.  Despite this, in a 
range of conditions associated with iron excess, there is evidence that iron chelation is 
therapeutically beneficial.[29]  However, in the context of gastrointestinal disease it is 
specifically an excess of luminal iron within the large bowel that is detrimental and the 
chelation of this pool of iron presents itself as a potential therapeutic platform to improve 
intestinal health.   
 
In order to selectively chelate iron within the lumen of the colon the therapeutic compound 
must not be absorbable such that it reaches the large bowel and binds excess iron.    Non-
digestible fibres have been demonstrated to improve gastrointestinal health,[30] yet whether 
these effects are attributed to their iron binding properties is unknown. Sodium alginates which 
are fibres found within the human diet have previously been demonstrated to be both non-
absorbable and bind iron.[13, 14] The possible range of alginate compositions is huge due to 
the diversity in polymer length and G:M chemical composition.[31, 32]  How these 
compositional differences affect iron binding potential and subsequent in vitro and in vivo 
cellular iron modulation is unknown, with previously published reports being inconsistent in 
their findings.[14, 33-35] This inconsistency is likely due to the fact that chemically different 
alginates were used throughout these studies, and data presented in this study demonstrates 
the dependence of iron chelation bioactivity on alginate chemical composition. 
 
A range of alginates with different molecular weights and G:M compositions were primarily 
screened to assess their in vitro iron chelation potential.  This initial assessment identified only 
one alginate that was able to modulate iron metabolism in vitro.   Manucol LD decreased 
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ferritin expression by 60 % (Figure 1A and B), decreased total cellular iron by 62 % (Figure 
1C), restored TfR1 expression to control levels (Figure 1D) and decreased absorption of iron 
in Caco-2 cells by 70 % (Figure 2 A and B); this was the only alginate to have consistent iron 
chelation properties (all statistically significant to p < 0.05).  In vivo, Manucol LD was able to 
supress iron absorption by 71 % and increased the iron content found in faecal samples by 
45 % (p < 0.05) (Figure 3).  These two results are pivotal in demonstrating the mechanism of 
iron binding by Manucol LD within the gastrointestinal tract, where it can be inferred that 
Manucol LD is binding iron and keeping it chelated until defecation.  Where the iron is 
interacting with Manucol LD within the gastrointestinal tract remains unclear, however, as 
alginates are insoluble in low pH environments and form insoluble capsules, it is likely that 
iron chelation would not take place until Manucol LD reached more basic, distal regions of the 
gut.[36]  Interestingly, the concentrations of iron within the mucosa of gastrointestinal tissues 
increases from the small to the large bowel (stomach<duodenum<colon).  This is likely to be 
a consequence of either i) more effective iron transport across the brush border in the 
duodenum than within the colon, ii) the increased length of exposure to iron in the digesta 
within the colon, or iii) a combination of both.  This finding is supported by studies which have 
demonstrated that the colon is able to import iron but there is a lack of regulated iron efflux.[37]  
Thus unsurprisingly, Manucol LD had its greatest iron chelation effects within the colon 
decreasing iron absorption by 56 % (p < 0.05).  
 
Manucol LD has iron chelation effects both in vivo and in vitro however, what remains unclear 
is what the redox state and likely species of iron that alginate is chelating to within these 
experimental conditions. Since sodium ascorbate was included within the growth media in cell 
culture experiments it is likely that the supplemented ferrous iron will remain in the ‘free’ 
ferrous form (‘free’ referring to its availability to chelation by competing ligands) which would 
suggest that Manucol LD is certainly binding to free ferrous iron.  In addition previous reports 
have indicated that alginate will also bind ferric iron.[13]  It can be inferred that Manucol LD is 
likely to have iron chelation ability towards ferrous and ferric ions, yet this does not rule out 
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the possibility that iron could be forming nanoparticulate species within the gastro-intestinal 
tract,[38] which alginates have also been documented to stabilise.[39]  If indeed iron in its 
‘free’ form is present within the colon then these data suggest that Manucol LD is able to bind 
such a form of iron and possibly nanoparticulate forms based on previously published 
reports.[13]  However, the species of iron present within the colon is currently unknown and 
could be in its ‘free’ state, bound to other dietary or endogenous intestinal compounds or even 
as particulate mineralised species.[38, 40, 41] 
 
To interrogate the chemical characteristics of alginate required for iron chelation and 
subsequent modulation of cellular iron metabolism, Manucol LD and Manucol DH (the latter 
an alginate with similar G:M composition but different polymer length) were subject to 
structural modification by alginate degradation (through heating) and M→G unit conversion 
(by exposure to alginate epimerase AlgE1).  Determination of the heating time required to 
reduce molecular weight by specific amount allowed the calibration of intrinsic viscosity 
change against heating time (Figure 4A).  Heat degradation of Manucol DH at 100 °C 
decreased with heating time as previously reported.[42]  It was estimated that heating Manucol 
DH for ca. 3 hours would provide an intrinsic viscosity value of 1200 mL g-1, which would give 
a molecular weight similar to that of Manucol LD (145 kDa).  As such, heating Manucol DH for 
180 min produced a shorter chain alginate (analogous to Manucol LD) that, when co-cultured 
in vitro with iron decreased iron induced ferritin expression by 50 % (p < 0.05) (Figure 4B).  As 
a control, Manucol DH was heated for longer periods of time (250 min) to produce shorter 
molecular weight products.  Subsequent co-culture of these ADPs resulted in diminished iron 
chelation ability to that observed with the 180 min ADPs as ferritin levels were not significantly 
different to the iron only control. As a further control, RKO cells were co-cultured with iron in 
the presence of D-glucuronic acid (DGA) to examine if the individual monomeric acid-unit was 
able to modulate cellular iron metabolism; DGA also had no significant effects on ferritin 
expression or intracellular 59Fe concentration.  These results demonstrate the importance of 
polymer length on iron binding ability, and it has recently been reported how the polymeric 
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nature of alginate orchestrates iron chelation.[13]  Thus in summary an alginate molecular 
weight of approximately 145 kDa is required for maximal iron chelation bioactivity.   
   
It is plausible that Manucol LD has a tertiary and secondary structure that forms an iron binding 
pocket or cavity; this structure is formed by the specific MG sequence of the alginate.  The 
iron binding site acts as a nucleation site for iron deposition and such mechanisms have been 
previously reported for other biopolymers.[39]  If this were the case, then alteration of the G:M 
ratio and thus GM sequence on Manucol LD would disrupt the formation of this binding site.  
Indeed, data presented in this study has demonstrated this.  Alginate Epimerase 1 was utilised 
to convert Manucol LD (G:M 38:62) to EpLD (G:M 77:23).  Subsequent co-culture of EpLD in 
the presence of iron did not reduce ferritin expression as demonstrated for native Manucol LD.  
Such results demonstrate the importance of a specific alginate G:M ratio and GM sequence 
in iron chelation bioactivity.  To fully confirm the uniqueness of Manucol LD, high resolution 
NMR spectroscopy showed that Manucol DH and Manucol LD (two alginates with similar G:M 
ratio) do indeed have different GM sequence homologies, where differences in MM and GM 
(or MG) diad frequencies are most apparent.  
 
In summary, data presented here identifies a unique alginate, with a specific chemical 
composition and polymeric length that demonstrates optimal iron chelation properties both in 
vitro and in vivo.  This data not only explains why inconsistencies have previously been 
reported on alginate modulation of cellular iron metabolism but also detail the required 
chemical characteristics of an alginate for iron chelation bioactivity.  Importantly, if Manucol 
LD is to be used to chelate excess colonic luminal iron, it will require formulating so as to 
ensure colonic delivery. Without employment of a colonic delivery platform our data might 
predict that chronic consumption of Manucol LD could lead to iron deficiency, due to iron 
chelation within the small bowel.     In the context of modulating the intestinal microbiome, it is 
known that iron is able to alter microbial colonisation to a more pro-inflammatory enterotype 
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and it could be envisaged that Manucol LD could supress the colonisation of these ‘non-
beneficial’ bacteria (such as Bacteroides) through the chelation of luminal iron.[11, 43, 44]  
Further to this, alginates may have pre-biotic effects acting as a support scaffold for the 
colonisation of beneficial bacteria and as such further testing of these pro- and pre-biotic 
effects in man is required.  
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TABLES  
TABLE 1 Summary of analytical ultracentrifugation data to determine alginate molecular 
weight (kDa) and nuclear magnetic resonance spectroscopy to determine 
alginate G:M composition. 
Alginate MW (kDa) G:M 
RF 230 ± 10 60:40 
KEL 220 ± 15 46:54 
GHB 180 ± 18 53:47 
DH 170 ± 6 40:60 
AFH 155 ± 5 29:71 
LD 145 ± 5 38:62 
LFR 74 ± 3 62:38 
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FIGURE LEGENDS 
FIGURE 1 (A) Ferritin protein expression in RKO cells co-cultured with iron (Fe) +/- 
sodium alginates (LD, DH, GHB, LFR, KEL, RF and AFH) for 24 hours.  Data 
points represent mean fold change in protein expression normalised to β-actin, 
relative to control.  (B)  Ferritin protein expression in RKO cells co-cultured with 
different iron concentrations (Fe) +/- LD, DH, GHB, LFR, KEL, RF and AFH for 
24 hours.  Data points represent mean fold change in protein expression 
normalised to β-actin, relative to control.   (C)  Total iron concentrations in RKO 
cells cultured +/- Manucol LD for 24 hours.  (D)  Transferrin receptor expression 
in RKO cells incubated with iron +/- Manucol LD.  Data points represent mean 
fold change in protein expression, normalised to β-actin, relative to control.  
Error bars denote ± SEM, * represents statistical significance p < 0.05 vs iron 
only control and n = 3. 
FIGURE 2 (A) Iron concentration in Caco-2 cells incubated with iron +/- Manucol LD.  (B)  
59Fe concentrations at 0.5, 4 hours and 24 hours in the apical chamber 
following culture with iron +/- Manucol LD.  Error bars denote ± SEM, * 
represents statistical significance, p < 0.05 vs iron only control. 
FIGURE 3 (A) Whole carcass (total absorbed iron across the gut) 59Fe CPM 
concentrations 48 hours post administration with iron +/- Manucol LD.  (B)  
Faecal 59Fe CPM 48 hours post administration with iron +/- Manucol LD.  (C)  
Stomach, duodenum and colon 59Fe CPM concentrations 48 hours post 
administration of iron +/- Manucol LD.  (D) Total accountable 59Fe CPM 
concentrations for each experimental group compared to the dose 
concentration of 59Fe administered.  Error bars denote ± SEM, * and ** 
represents statistical significance p < 0.05 and 0.005 vs iron only control. 
FIGURE 4 (A) Manucol DH relative viscosity (𝜂rel) decreases by heating at 100 °C with a 
plot of intrinsic viscosity against heating time.  Error bars denote ± SEM.  (B) 
Ferritin protein expression in RKO cells incubated with iron +/- Manucol DH 
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heat degradation products for 24 hours.  Data points represent mean fold 
change in protein expression, normalised to β-actin, relative to control.  Error 
bars denote ± SEM, * represents statistical significance p < 0.05 vs iron only 
control and n = 3.  (C) 59Fe concentrations in RKO cells incubated with iron 
challenged +/- DGA .  Data points represent mean fold change in protein 
expression, normalised to β-actin, relative to control.  Error bars denote ± SEM.  
NS indicates no statistical significance. (D) Ferritin protein expression in RKO 
cells incubated with iron +/- DGA.  Data points represent mean fold change in 
protein expression, normalised to β-actin, relative to control.  Error bars denote 
± SEM.  NS indicates no statistical significance. 
FIGURE 5 Experimental (red) and simulated (blue) NMR spectra of alginate (A) Manucol 
DH and (B) Manucol LD for the region of protons 1 and 5 of mannuronic acid 
and glucuronic acid.  (C)  CD spectra and representative UV-Visible spectra of 
Manucol LD and Epimerised Manucol LD.  (D) Ferritin expression in RKO cells 
incubated with iron +/- Manucol LD and EpLD.  Data points represent mean 
fold change in protein expression, normalised to β-actin, relative to control.  
Error bars denote ± SEM, * represents statistical significance p < 0.005 vs iron 
only control and n = 3. 
 
 
 
 
 
 
